NEW YORK - IO Biotech (IOBT), a clinical-stage biopharmaceutical company valued at $58.63 million, has published results from a preclinical study on its second cancer vaccine candidate, IO112, which ...

Video above: Judge blocks Trump’s order to end birthright citizenship Sen. Katie Britt is cosponsoring a bill that would effectively codify President Trump's order on birthright citizenship in the ...

including potential BLA submission for IO102-IO103 in 2025Commitment is part of the European Investment Bank’s strategy to support biotech companies with cutting-edge expertise in therapeutic ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...